Forbion secures over €2B across two new Funds to support Innovative Biotech Companies
Dutch life sciences venture capital firm Forbion has raised over €2 billion across two new funds: Forbion Growth Opportunities III and Forbion Ventures VII, bringing the firm’s total assets under management to €5 billion. Both funds exceeded their initial targets, securing €1.2 billion and €890 million, respectively.

The best Articles in our Network

Previous
Next